Advisory Services Network’s Mineralys Therapeutics MLYS Stock Holding History

Advisory Services Network’s Portfolio MLYS Stock Details MLYS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.11K	Buy	+41	New	+$1.2K	﹤0.01%	4285

Other funds holding MLYS

Catalys Pacific Tokyo, Japan $231M AUM 83.19% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Advisory Services Network's MLYS Position: Q1 2026 in Review

Advisory Services Network opened a new position in Mineralys Therapeutics (MLYS) in Q1 2026: 41 shares worth $1.11K. The stake represents ﹤0.01% of the portfolio and ranks #4285 among its holdings.

214 funds tracked by Wall St. Rank hold MLYS as of Q1 2026.

Advisory Services Network held 41 shares of Mineralys Therapeutics worth $1.11K as of Q1 2026.
Mineralys Therapeutics was a new Advisory Services Network position in Q1 2026.
Mineralys Therapeutics made up ﹤0.01% of Advisory Services Network's portfolio in Q1 2026, its #4285 holding.
214 funds tracked by Wall St. Rank held Mineralys Therapeutics as of Q1 2026.

Based on Advisory Services Network's 13F filing for Q1 2026, filed 15 May 2026.